Stocks TelegraphStocks Telegraph
Stock Ideas

CUE Stock Forecast and Stock Price Prediction

NASDAQ : CUE

Cue Biopharma

$0.36
-0.0324-8.25%
At Close 4:00 PM
$0.38
+0.0165+4.58%
After-Market 08:30 PM
67.17
BESG ScoreESG Rating

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$0.3610.99%Since 2 Weeks
Predicted Price$0.27-25.02%For 2 Weeks
Upper Predicted Price$0.35-1.98%For 2 Weeks
Lower Predicted Price$0.19-47.4%For 2 Weeks

Forecast Score Based on 2 Weeks

020406080100
37

Based on our forecast, the price of CUE will decline by -25.02% over the next 2 Weeks and hit $0.27 by Friday, January 23, 2026. In that time frame, CUE's share price is expected to range between $0.19 and $0.35.

BearishAverageBullish
DatePredicted LowerPredictedPredicted Upper
Jan 23, 20260.180.270.35
Jan 22, 20260.220.310.39
Jan 21, 20260.200.280.36
Jan 20, 20260.200.280.36
Jan 19, 20260.220.300.39
Jan 16, 20260.220.310.40
Jan 15, 20260.280.350.44
Jan 14, 20260.240.330.42
Jan 13, 20260.250.330.41
Jan 12, 20260.260.350.43

CUE shares fell -8.25% in Friday, January 9, 2026's trading session, dropping from a previous close of $0.39 to move at $0.36. The stock demonstrated notable intraday movement (see CUE's key stats for a full breakdown), fluctuating between $0.34 and $0.40, a +17.59% trading range. While recent weeks have seen some volatility, CUE has managed to secure a +10.99% gain over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 877K shares changing hands, 345.54K more than the previous session. This amounted to $316.16K in total market activity.

Will CUE Continue Its Downward Trend?

According to analyst ratings and projections for CUE, Cue Biopharma, Inc. shares are anticipated to decrease by -2.88%, potentially reaching $0.35 per share by January 23, 2026. Short-term technical indicators for CUE currently suggest a bearish sentiment. This aligns with the stock's recent performance, as it has recorded 19 negative trading days within the past 30 sessions. Based on the CUE stock forecast, now is not the best time to buy CUE stock because its current trading price is +35.58% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on CUE covering social and institutional perspectives.

CUE Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into CUE's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 40.90% to 47.97%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 40.81%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 43.88%, maintains a neutral outlook for the long term. Insights into CUE's shareholder base show how institutional investors are positioning themselves during these momentum shifts

Cue Biopharma Short-Term Forecasts

CUE Forecast For Next 5 Days

Our algorithm anticipates Cue Biopharma (CUE) stock could hit $0.21 by Jan 08, 2026. This represents a -40.92% rise from today's price, following a +28.65% change over the past five days.

CUE Forecast For Next 30 Days

Based on analysis of market trends, the outlook for Cue Biopharma, Inc. (CUE) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $0.17, which would mean a -52.84% decrease from the current price of $0.36. Projections for this period range from a high of $0.31 to a low of $0.06.

CUE Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for Cue Biopharma's price over the next three months point to a rise. CUE stock is expected to peak at $2.54 on Jan 16, 2026 before potentially dipping to $0.05 on Mar 02, 2026. On average, CUE is likely to trade around $1.29 in the coming 90 days.

Cue Biopharma Stock Forecast 2025

Based on our predictive models, Cue Biopharma (CUE) is expected to trade between $0.00 and $3.17 throughout 2026. This would result in an average price of $1.37, potentially offering investors a +280.03% return from current levels.

Cue Biopharma, Inc. Monthly Forecast 2026

January 2026

According to our latest forecast models, Cue Biopharma, Inc. (CUE) is positioned to show a strong performance in January 2026. The price is predicted to move between $1.57 and $2.54, settling at an average of $2.14. This could translate to a +493.62% gain.

February 2026

Based on current market signals, Cue Biopharma, Inc. is projected to trend february 2026. We forecast a trading range from $0.06 to $1.75, with a likely average price of $0.77. Investors could expect a potential return of +113.59%.

March 2026

Our predictive algorithms indicate Cue Biopharma, Inc. stock may see a shift in March 2026. The expected range spans $0.05$1.84, with an average target of $1.08. This represents a positive outlook and a possible gain of +199.58%.

April 2026

Analyzing established trends, Cue Biopharma, Inc. looks set to move in April 2026. Projections place the stock between $0.68 and $1.72, averaging around $1.15. This suggests a +219.00% gain from current levels.

May 2026

Market indicators suggest Cue Biopharma, Inc. could experience notable changes during May 2026. Prices could fluctuate within $1.30 to $2.92, with a midpoint forecast of $2.06. The stock might deliver a +471.43% gain.

June 2026

Forecasting for June 2026, models estimate that Cue Biopharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $1.45 and $3.17, averaging $2.86. This signals a positive trajectory with potential returns around +693.34%.

July 2026

According to our latest forecast models, Cue Biopharma, Inc. (CUE) is positioned to show a strong performance in July 2026. The price is predicted to move between $0.63 and $2.15, settling at an average of $1.64. This could translate to a +354.92% gain.

August 2026

Based on current market signals, Cue Biopharma, Inc. is projected to trend august 2026. We forecast a trading range from $0.47 to $1.70, with a likely average price of $1.44. Investors could expect a potential return of +299.45%.

September 2026

Our predictive algorithms indicate Cue Biopharma, Inc. stock may see a shift in September 2026. The expected range spans $0.00$1.20, with an average target of $0.27. This represents a cautious outlook and a possible loss of -25.10%.

October 2026

Analyzing established trends, Cue Biopharma, Inc. looks set to move in October 2026. Projections place the stock between $0.00 and $1.75, averaging around $0.52. This suggests a +44.24% gain from current levels.

November 2026

Market indicators suggest Cue Biopharma, Inc. could experience notable changes during November 2026. Prices could fluctuate within $0.04 to $2.56, with a midpoint forecast of $1.90. The stock might deliver a +427.05% gain.

December 2026

Forecasting for December 2026, models estimate that Cue Biopharma, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.18, averaging $0.62. This signals a positive trajectory with potential returns around +71.98%.

CUE's history of dividends and stock splits also plays a role in long-term investor confidence.

Frequently Asked Questions

What is the CUE stock price prediction for next 2 weeks?
According to our price prediction algorithm,Cue Biopharma, Inc. (CUE) price will be around $0.27 in the next 2 weeks. This means it will decrease by -25.02% from the last closing price. This prediction may vary from other time period filters for CUE stock.
What can be the highest Possible price of CUE stock in next 2 weeks?
Our forecast algorithm expects that in 2 weeks, CUE can achieve the highest price of $0.35 which is -1.98% lower than last closing price. This prediction may vary from other time period filters for CUE stock.
What can be the lowest Possible price of CUE stock in next 2 weeks?
As per the forecast and algorithmic analysis, CUE stock price can be as low as $0.19 which is -47.40% lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for CUE stock.
Will CUE stock go high in the next 2 weeks?
No, our stock forecasting algorithm shows that CUE stock will lose-25.02% in the next 2 weeks. This prediction may vary from other time period filters for CUE stock.
What is CUE stock last closing price?
Last closing price of CUE stock was $0.36.
What is CUE stock price prediction?
CUE stock price prediction means predicting the future closing prices of CUE stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of CUE stock in a certain time period.
How we predict CUE stock future prices?
If you are searching for CUE stock forecast, analysis or price prediction, then you might be wondering what Cue Biopharma, Inc. (CUE) will do in the future. Our CUE price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This CUE price prediction will likely answer most of your questions.
How frequent we update CUE stock predictions?
We are updating the forecasts for the CUE stock on daily basis.
Is using ML forecasting for CUE stock a good way?
Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.
Is the Prediction for CUE stock same for all the time periods?
No, the prediction for CUE stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph